Pharma Lecture With Dr. Maria Yña Eluisia T. Pereyra-Borlongan 1
Pharma Lecture With Dr. Maria Yña Eluisia T. Pereyra-Borlongan 1
Pereyra-Borlongan 1
DRUG METABOLISM
Sites of Drug Metabolism
Drug Metabolism LIVER (most important organ for drug metabolism)
metabolic pathways alter drug activity and their KIDNEYS
susceptibility to excretion TISSUE COMPARTMENTS
Two phases o few drugs (eg. esters) are metabolized in many
o Phase 1 or Functionalization Rxn tissues (eg. liver, blood, intestinal wall)
o Phase 2 or Conjugation Rxn because of the broad distribution of their
enzymes
Phase I Reactions
convert the parent drug to a more polar (water-soluble) or Drug Biotransformation
more reactive product by unmasking or inserting a polar most often due to genetic or drug-induced differences
functional group gender is important for only a few drugs
EXAMPLES: oxidation, reduction, deamination, hydrolysis o first-pass metabolism of alcohol (M > F)
primary determinant of clearance
MNEMONICS – Phase I Reactions o variations must be considered carefully when
A HORDe of PHASE I REACTIONS designing or modifying a dosage regimen
Hydrolysis Reduction
Oxidation Deamination Genetic Factors
drug-metabolizing systems differ among families or
Cytochrome P450 Enzymes populations in genetically determined ways
Also called mixed-function oxidases recent advances in genomic techniques allow screening
High concentrations in the smooth endoplasmic reticulum for a huge variety of polymorphisms
of the liver (pharmacogenomics)
Not highly selective in their substrates
Approximately 75% are metabolized by: CYP3A4 or Examples in Pharmacogenomics
CYP2D6 HYDROLYSIS OF ESTERS
succinylcholine metabolism by pseudocholinesterase
Examples of Phase I Reactions ACETYLATION OF AMINES
fast and slow acetylation of isoniazid, hydralazine and
procainamide
OXIDATION
debrisoquin,
Enzyme Inductionsparteine, phenformin,
dextromethorphan,
results metoprolol,
from increased and
synthesis of tricyclic P450
cytochrome
antidepressants
enzymes and heme
several days are usually required to reach maximum
induction
most common strong inducers are carbamazepine,
phenobarbital, phenytoin, and rifampin
PENICILLINS
Penicillin Resistance
Suicide Inhibitors enzymatic hydrolysis of beta-lactam ring by formation of
bind irreversibly to metabolizing enzymes beta-lactamases (penicillinases)
EXAMPLES: ethinyl estradiol, norethindrone, o EXAMPLE: Staphylococcus aureus
spironolactone, secobarbital, allopurinol,
o beta-lactamase inhibitors (clavulanic acid,
fluroxene, PTU
sulbactam, tazobactam) prevent inactivation
structural change in target PBPs
o EXAMPLES: MRSA, pneumococci,
ANTIBIOTIC AGENTS enterococci
changes in the porin structures in outer cell wall
impeding access of penicillins to PBPs
OVERVIEW
o EXAMPLE: Pseudomonas aeruginosa
No activity against gram-positive bacteria or MOA Interferes with a late stage in cell wall synthesis in
anaerobes gram-positive organisms
Given IV Uses Infections due to gram-positive bacteria
Synergistic with AG SE Nephrotoxicity
Renal excretion Notes Reserved for topical use only due to marked
nephrotoxicity
MISCELLANEOUS
CYCLOSERINE [C]
CLAVULANIC ACID [B] MOA Blocks incorporation of D-Ala into the
SimD SULBACTAM [B], TAZOBACTAM [B] pentapeptide side chain of the peptidoglycan
Class Beta-lactamase inhibitor Uses Drug-resistant tuberculosis (2nd line drug)
MOA Inhibits inactivation of penicillins by bacterial SE Neurotoxicity (tremors, seizures, psychosis)
beta-lactamase (penicillinase) Notes Only used as a second-line agent in TB
Uses Infections against beta-lactamase producing
gonococci, streptococci, E. coli and H. influenzae DAPTOMYCIN [B]
SE Hypersensitivity, Cholestatic jaundice MOA Binds to cell membrane causing depolarization
Notes Usual combinations include Amoxicillin- and rapid cell death
Clavulanate, Ampicillin-Sulbactam, Piperacillin- Uses Infections caused by G(+) bacteria including
Tazobactam sepsis and endocarditis
Most active against plasmid encoded B SE Myopathy
lactamases (Gonococci, Streptococci, E coli and Notes More rapidly bacteridicidal than Vancomycin
H. Influenzae) Inactivated by pulmonary surfactants so cannot
Not good inhibitor of inducible chromosomal B be used against pneumonia
lactamases (Enterobacter,Pseudomonas, Monitor Creatine Phosphokinase weekly to
Serratia) check for severity of myopathy
NOT Bactericidal (only destabilizes bacterial cell
VANCOMYCIN [C if parenteral, B if per orem] membrane)
SimD TEICOPLANIN [B], DALBAVANCIN [C[,
TELAVANCIN [C] OTHER DRUGS ACTING ON CELLWALL
Class Glycopeptide FOSFOMYCIN Inactivates the enzyme UDP-N-
MOA Inhibits cell wall synthesis by binding to the D- [B] acetylglucosamine-3-
Ala-D-Ala terminus of nascent peptidoglycan enolpyruvyltransferase which is
inhibit transglycosylation prevent elongation important in peptidoglycan synthesis (very
and cross-linking of peptidoglycan chain early stage of bacterial cell wall synthesis)
Uses Serious infections caused by drug-resistant gram- prevents formation of N-
positive organisms (MRSA), sepsis, endocarditis & acetylmuramic acid (a peptidoglycan
meningitis, Pseudomembranous colitis precursor molecule); for uncomplicated
SE Red Man syndrome, Nephrotoxicity, Ototoxicity, UTI; safe for pregnant patients; renal
Chills, Fever, Phlebitis excretion; resistance emerges rapidly;
Notes Reserved for serious life-threatening infections synergistic with Beta lactam and
Treat red man syndrome by slowing the rate of quinolones
infusion
Use oral formulation for Pseudomembranous BACTERIAL PROTEIN SYNTHESIS INHIBITORS
colitis
Narrow spectrum Treat red man syndrome by
MNEMONIC - Protein Synthesis Inhibitors
slowing the rate of infusion
A = Aminoglycosides
VRSA and VRE are due to D-Ala-D-Lactate
T = Tetracyclines
formation
C = Chloramphenicol
Teicoplanin and telavancin are not absorbed in
E = Erythromycin (Macrolides)
the GIT thus used for bacterial enterocolitis, L = Lincosamides (Clindamycin)
they are also eliminated unchanged in the urine L = Linezolid
Decrease dose for renally impaired patients S = Streptogramins
Dalbavancin has very long t1/2 (6-11 days) which
permits once-weekly dosing and is more active
than Vancomycin
BACITRACIN [C]
Class Peptide antibiotic
Pharma Lecture with Dr. Maria Yña Eluisia T. Pereyra-Borlongan 6
NEOMYCIN
SimD KANAMYCIN, PAROMOMYCIN
Class Aminoglycoside
MOA Inhibit protein synthesis by binding to 30S
subunit. Bactericidal.
Uses Skin infections, Bowel preparation for elective Antifolate Drugs
surgery (to decrease aerobic flora), Hepatic
encephalopathy, Visceral leishmaniasis Sulfonamides
(paromomycin) weakly acidic compounds that have a common chemical
SE Hypersensitivity, Nephrotoxicity (reversible), nucleus resembling p-aminobenzoic acid (PABA)
Ototoxicity (irreversible), Neuromuscular solubility may be decreased in acidic urine
blockade
o combination of 3 separate sulfonamides (triple
Notes Limited to topical and oral use (Neomycin) sulfa) to reduce the likelihood that any one
Reverse neuromuscular blockade with calcium
drug will precipitate
gluconate and neostigmine
classification
Kanamycin is most ototoxic
Short Acting Intermediate Long Acting
Acting
SPECTINOMYCIN
Sulfacytine Sulfadiazine Sulfadoxine
Class Aminoglycoside
Sulfisoxazole Sulfamethoxazole * Pyrimethamine
MOA Inhibit protein synthesis by binding to 30S
Sulfamethizole Sulfapyridine
subunit. Bactericidal.
* Trimethoprim
Uses Drug-resistant gonorrhea, Gonorrhea in penicillin-
allergic patients
Trimethoprim
SE Nephrotoxicity (reversible), Ototoxicity
structurally similar to folic acid
(irreversible), Neuromuscular blockade, Anemia
weak base that is trapped in acidic environments
Notes No cross-resistance with other drugs used in
reaches high concentrations in prostatic and vaginal
gonorrhea
Given Intramuscularly fluids
Toxicity of Sulfonamides
HYPERSENSITIVITY
o spectrum: EM, SJS/TEN, PAN, exfoliative
dermatitis
o most common drug triggers
o cross-allergenicity should be assumed
GASTROINTESTINAL DISTRESS
o nausea, vomiting, diarrhea and mild hepatic
dysfunction
HEMATOTOXICITY
o granulocytopenia, thrombocytopenia, aplastic
anemia
Resistance to Antifolate Drugs
o cause acute hemolysis in G6PD deficient patients
plasmid-mediated and results from:
o Toxicity of Sulfonamides
o decreased intracellular accumulation of the
NEPHROTOXICITY
drugs
o crystalluria, hematuria
o increased production of PABA by bacteria
DRUG INTERACTIONS
o decrease in the sensitivity of dihydropteroate
o displace protein binding affecting levels of
synthase to sulfonamides
warfarin and methotrexate
o displace bilirubin binding sites leading to
SILVER SULFADIAZINE [B] kernicterus
SimD MAFENIDE ACETATE [C] o
Class Sulfonamide Kernicterus
MOA Inhibit dihydropteroate synthase. Bacteriostatic. caused by increased levels of unconjugated bilirubin
Uses Burn infections due to immaturity of fetal blood brain barrier
SE GI upset, Acute hemolysis in G6PD deficiency, histopathology
Nephrotoxicity, Hypersensitivity (assume cross- o bilirubin deposits in subcortical nuclei and basal
hypersensitivity, SJS/TEN), Hematotoxicity, Drug ganglia
interactions, Kernicterus clinical presentation
Notes Displaces protein binding of other drugs/bilirubin o hypo/hypertonia, lethargy, high-pitched cry,
opisthotonos
CO-TRIMOXAZOLE [D]
Class Sulfonamide Quinolones
MOA Sequential blockade of dihydropteroate synthase
MOA of Quinolones
(Sulfamethoxazole) and dihydrofolate reductase
interfere with bacterial DNA synthesis by inhibiting:
(Trimethoprim). Bactericidal.
o topoisomerase II (DNA Gyrase) in gram-negative
Uses Urinary tract, respiratory, ear and sinus infections
organisms
(Haemophilus, Moraxella, Aeromonas), P jiroveci
prevents relaxation of supercoiled DNA
pneumonia, Toxoplasmosis, Nocardiosis, Cholera
o topoisomerase IV in gram-positive organisms
(backup), Typhoid fever, Shigellosis
interferes with the separation of
SE GI upset, Acute hemolysis in G6PD deficiency, replicated chromosomal DNA during
Nephrotoxicity, Hypersensitivity (assume cross- cell division
hypersensitivity, SJS/TEN), Hematotoxicity, Drug
usually bactericidal against susceptible organisms
interactions, Kernicterus
exhibit postantibiotic effect
Notes Displaces protein binding of other drugs/bilirubin
should not be taken with other preparations containing
Low solubility in acidic urine causing formation
cations (should be taken 2 hours before or 4 hours after
of stones
any product containing cations)
Resistance is due to plasmin-mediated (decreased
may damage growing cartilage and cause arthropathy
intracellular accumulation of the drug, increased
production of PABA by bacteria, decreased
Resistance to Fluoroquinolones
sensitivity of dihydropteroate synthetase to
decreased intracellular accumulation of the drug via the
sulfas and production of dihydrofolate
production of efflux pumps
reductase that has decreased affnity for the
changes in porin structure
drug
changes in the sensitivity of the target enzymes via point
Sulfonamides are formulated in a 5:1 ratio with
mutations in the antibiotic binding regions
trimethoprim
Classification of Fluoroquinolones
Other Sulfonamides and Antifolate Drugs: 1ST GENERATION
Sulfisoxazole : only for lower UTI o Nalidixic acid, Cinoxacin, Rosoxacin, Oxolinic
Sulfadiazine-Pyrimethamine: DOC for Toxoplasmosis
acid
Sulfadoxine-Pyrimethamine: 2nd line agent for Malaria 2ND GENERATION
Pharma Lecture with Dr. Maria Yña Eluisia T. Pereyra-Borlongan 10
oCiprofloxacin, Ofloxacin, Norfloxacin, Notes Avoid use in young children and pregnant women
Lomefloxacin, Enoxacin Enhance toxicity of methylxanthines
3RD GENERATION (theophylline)
o Levofloxacin, Gemifloxacin, Moxifloxacin, Grepafloxacin withdrawn due to severe
Sparfloxacin, Grepafloxacin, Gatifloxacin, cardiotoxicity (arrhythmias), Gatifloxacin has
Pazufloxacin, Tosufloxacin, Balofloxacin also been withdrawn due to Diabetes mellitus
4TH GENERATION Moxifloxacin ha shepatice clearance lower
o Trovafloxacin, Alatrofloxacin, Prulifloxacin, urinary levels, so use in UTI is not recommended
Clinafloxacin High resistance esp for C. jejuni, gonococci, G+
cocci like MRSA, Pseudomonas and Serratia
Antimicrobial Spectrum of Fluoroquinolones Are used as alternative to Ceftriaxone and
1st Generation: urinary tract infections Cefixime in gonorrhea
2nd Generation: gram negatives, gonococci, gram positive Ofloxacin can be used against C. trachomatis
cocci and Mycoplasma "Respiratory Quinolones"
3rd Generation: less gram negative and more gram positive Moxifloxacin and Gemifloxacin are the newest
activity, streptococci and enterococci members of this family and are condisered to
4th Generation: broad spectrum, including anaerobes have the broadest spectrum of activity with
o with increasing generation, increasing gram increased activity aginst anaerobes ang atypical
positive activity agents
o unlike cephalosporins where increasing FQ elimination is via kidneys by tubular secretion
generation leads to increasing gram negative (may compete with probenecid for excretion)
activity EXCEPT Moxifloxacin
NEVER use moxifloxacin in UTI
CIPROFLOXACIN [C] Levofloxacin is used in CAP caused by
SimD OFLOXACIN [C], NORFLOXACIN[C], Chlamydia, Mycoplasma and Legionella
LOMEFLOXACIN [C], ENOXACIN [C] Gemifloxacin, Levofloxacin and Moxifloxacin
Class Fluoroquinolone (2nd Generation) can prolong Q
MOA Inhibits DNA replication by binding to DNA gyrase Levofloxacin has superior activity against G(+)
and topoisomerase IV. Bactericidal. bacteria including S. pneumoniae ; All have
Uses Urinary tract infections and GIT infections (gram- relatively long t1/2 permitting once daily dosing
negative rods (such as Shigella, Salmonella, ETEC Oral absorption is impaired by cations
& Campylobacter), gonococci, gram positive Gatifloxacin can cause hyperglycemia in DM Px
cocci), Atypical pneumonia, Tuberculosis (2nd and hypoglycemia in patients also receiving OHA
line drug), Infection of soft tissue, bones and joints and was withdrawn from the market in 2006
; Intra-abdominal MDR organisms (such as
(USA)
Pseudomonas Enterobacter)
SE Gastrointestinal distress, CNS effects (dizziness,
TROVAFLOXACIN [C]
headache), insomnia, skin rash, abnormal LFTs,
SimD ALATROFLOXACIN [C], PRULIFLOXACIN,
Tendonitis and Tendon rupture
CLINAFLOXACIN
Notes Avoid use in young children and pregnant women
Class Fluoroquinolone (4th Generation)
Enhance toxicity of methylxanthines
MOA Inhibits DNA replication by binding to DNA gyrase
(theophylline)
and topoisomerase IV. Bactericidal.
Ciprofloxacis is the most active agent against
Uses Broad spectrum activity (gram-negatives, gram-
Gram Negative orgamisms esp. Pseudomonas
positives), Enhanced activity against anaerobes
General properties of quinolones: good oral
SE Gastrointestinal distress, CNS effects (dizziness,
bioavailability, high Vd, t1/2 3-8hrs, absorption is
headache), Tendinitis, QTc prolongation,
impeded by antacids, elimination is via kidneys by
Hepatotoxicity (trovafloxacin)
tubular secretion (may compete with probenecid
Notes Avoid use in young children and pregnant women
for excretion) EXCEPT for MOXIFLOXACIN
Enhance toxicity of methylxanthines
Norfloxacin does not achieve adequte plasma
(theophylline)
levels for use in systemic infections
Widest spectrum of activity among
fluoroquinolones
LEVOFLOXACIN [C]
SimD SPARFLOXACIN [C], MOXIFLOXACIN [C],
Miscellaneous
GEMIFLOXACIN [C], PAZUFLOXACIN,
TOSUFLOXACIN, BALOFLOXACIN
METRONIDAZOLE [B]
Class Fluoroquinolone (3rd Generation)
SimD TINIDAZOLE [C], SECNIDAZOLE [C]
MOA Inhibits DNA replication by binding to DNA gyrase
and topoisomerase IV. Bactericidal. Class Nitroimidazole, Antiprotozoal
Uses Lung infections caused gram-positive cocci, MOA Reactive reduction by ferredoxin forming free
Atypical pneumonia (Chlamydia, Mycoplasma), radicals that disrupt electron transport chain.
Tuberculosis (2nd line drug) Bactericidal.
SE Gastrointestinal distress, CNS effects (dizziness, Uses Anaerobic or mixed intra-abdominal infections,
headache), Tendinitis, QTc prolongation Vaginitis (Trichomonas, Gardnerella),
Pseudomembranous colitis, Brain abscess,
Protozoal infections
Pharma Lecture with Dr. Maria Yña Eluisia T. Pereyra-Borlongan 11
Delays the emergence of resistance to dapsone Dose adjustment id needed in renal patients
RIFAXIMIN is a Rifampin derivative that is not Always used in combination with other drugs for
absorbed in the GIT, and so is used for the TB
prevention of hepatic encephalopathy, for Take with meals
treatment of traveler’s diarrhea, (off-label use:
for IBS and Pseudomembranous colitis) STREPTOMYCIN [D]
Resistance is due to changes of drug sensitivity Class Antimycobacterial (aminoglycoside)
of the polymerase enzyme MOA Inhibit protein synthesis by binding to S12
Undergoes enterohepatic recirculation ribosomal subunit. Bactericidal.
Orange-colored metabolites Uses Tuberculosis (for Drug-resistant strains),
Delay emergence of resistance to dapsone Tularemia, Bubonic plague, Brucellosis
Rifabutin is equally effective as anti- SE Hypersensitivity, Nephrotoxicity (reversible),
mycobacterial agent with less drug interaction Ototoxicity (vestibulotoxic, irreversible),
and it is the preferred anti-TB for AIDS patients Neuromuscular blockade, Teratogen (congenital
Rifamixin is not absorbed in the GIT and is used deafness), Injection site reactions
for traveler's diarrhea Notes Synergistic effect with beta-lactam antibiotics
Best taken 1 hour before or 2 hours after meals Administered intramuscularly